Operating Cash Flow
Biogen Operating Cash Flow increased by 26.1% to $645.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 148.9%, from $259.30M to $645.50M. Over 3 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -15.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.23B | $805.30M | $838.30M | $161.80M | $736.50M | $661.00M | $455.30M | $487.00M | $592.40M | $12.50M | $553.20M | $625.80M | $935.60M | $760.90M | $259.30M | $160.90M | $1.27B | $511.90M | $645.50M |
| QoQ Change | — | -34.4% | +4.1% | -80.7% | +355.2% | -10.3% | -31.1% | +7.0% | +21.6% | -97.9% | >999% | +13.1% | +49.5% | -18.7% | -65.9% | -37.9% | +690.9% | -59.8% | +26.1% |
| YoY Change | — | — | — | — | -40.0% | -17.9% | +181.4% | -33.9% | -10.4% | — | +21.5% | +28.5% | +57.9% | >999% | -53.1% | -74.3% | +36.0% | -32.7% | +148.9% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Biogen's operating cash flow?
- Biogen (BIIB) reported operating cash flow of $645.50M in Q1 2026.
- How has Biogen's operating cash flow changed year-over-year?
- Biogen's operating cash flow increased by 148.9% year-over-year, from $259.30M to $645.50M.
- What is the long-term trend for Biogen's operating cash flow?
- Over 3 years (2021 to 2025), Biogen's operating cash flow has grown at a -15.4% compound annual growth rate (CAGR), from $3.64B to $2.20B.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.